Antivíricos
Os antivirais são compostos especificamente projetados para inibir a replicação e a propagação de vírus, desempenhando um papel crítico no tratamento e na prevenção de infecções virais. Nesta categoria, você encontrará uma seleção abrangente de agentes antivirais destinados exclusivamente a fins de pesquisa laboratorial. Esses produtos são essenciais para estudar os mecanismos virais, desenvolver novas terapias antivirais e compreender os padrões de resistência. Pesquisadores podem utilizar esses antivirais para investigar a eficácia e a segurança de tratamentos potenciais, contribuindo para o avanço da ciência médica e o desenvolvimento de medicamentos antivirais inovadores. A disponibilidade de diversos agentes antivirais apoia a pesquisa de ponta em virologia e aprimora nossa capacidade de combater doenças virais.
Foram encontrados 766 produtos de "Antivíricos"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Indinavir monohydrate
CAS:Indinavir monohydrate is an antiretroviral medication, which is a synthetic pharmaceutical compound, specifically a protease inhibitor, used in the treatment of HIV infection. It is derived from chemical synthesis processes that follow rigorous standards to produce a pharmacologically active compound. Indinavir functions by selectively inhibiting the HIV-1 protease enzyme, which is crucial for the viral replication cycle. By binding to the active site of the enzyme, indinavir prevents the cleavage of viral polypeptides, leading to the production of immature and non-infectious viral particles.Pureza:Min. 95%Foscarnet sodium
CAS:<p>Foscarnet sodium is a pyrophosphate analog antiviral agent with action on viral DNA polymerase and is used for treating cytomegalovirus and herpes simplex virus infections.</p>Fórmula:CNa3O5PPureza:Min. 95%Cor e Forma:White PowderPeso molecular:191.95 g/molFaldaprevir
CAS:Hepatitis C virus protease inhibitorFórmula:C40H49BrN6O9SPureza:Min. 95%Cor e Forma:White PowderPeso molecular:869.82 g/molZiresovir
CAS:<p>Respiratory syncytial virus (RSV) fusion (F) protein inhibitor</p>Fórmula:C22H25N5O3SPureza:Min. 95%Cor e Forma:PowderPeso molecular:439.53 g/molSofosbuvir - Bio-X ™
CAS:<p>Sofosbuvir is an antiviral agent that is used for the treatment of hepatitis C infections and is used in combination with other antiviral agents. This drug is an inhibitor of viral RNA polymerase called non-structural protein 5B (NS5B). As a result, it inhibits viral RNA replication.</p>Fórmula:C22H29FN3O9PPureza:Min. 95%Cor e Forma:PowderPeso molecular:529.45 g/molVicriviroc
CAS:<p>Vicriviroc is an investigational pharmaceutical compound, specifically classified as an HIV entry inhibitor. It originates from a synthetic source, designed to target the CCR5 co-receptor on human immune cells. The mode of action involves blocking this co-receptor, thereby preventing the HIV virus from binding and fusing with the host cell membrane. This inhibition effectively obstructs the virus's ability to enter and infect the host cells, particularly those within the chemokine receptor family.</p>Fórmula:C28H38F3N5O2Pureza:Min. 95%Peso molecular:533.63 g/molLobucavir
CAS:<p>Lobucavir is an antiviral compound with a mode of action that inhibits viral DNA polymerase. It is used for treating infections caused by herpesviruses and hepatitis B virus.</p>Fórmula:C11H15N5O3Pureza:Min. 95%Peso molecular:265.27 g/molWIN 54954
CAS:WIN 54954 is an orally available antiviral agent that inhibits Coxsackievirus and may be used in the study of small ribonucleic acid virus infections.Fórmula:C18H20Cl2N2O3Pureza:98.98%Cor e Forma:SolidPeso molecular:383.27Ref: TM-T61652
1mg51,00€5mg106,00€10mg168,00€25mg305,00€50mg492,00€100mg787,00€1mL*10mM (DMSO)119,00€IND24
CAS:<p>IND24 has anti-prion activity and can be used to study neurodegenerative diseases.</p>Fórmula:C21H17N3SPureza:99.64%Cor e Forma:SolidPeso molecular:343.44AMC-01
CAS:AMC-01 has potential antiviral activity and induces dose- and time-dependent inactivation of eIF2-α via phosphorylation of serine residue 51.Fórmula:C27H27BrN2O6Pureza:99.95%Cor e Forma:SolidPeso molecular:555.42(R,1R)-Tenofovir amibufenamide
CAS:(R,1R)-Tenofovir amibufenamide ((R,1R)-HS-10234) can be used as a Tenofovir prodrug, which can be taken orally and has antiviral activity.Fórmula:C22H31N6O5PPureza:98.79% - 99.02%Cor e Forma:SolidPeso molecular:490.49Ref: TM-T63290
1mg58,00€5mg133,00€10mg190,00€25mg328,00€50mg442,00€100mg598,00€200mg792,00€1mL*10mM (DMSO)145,00€BET-BAY 002
CAS:BET-BAY 002 is an effective BET bromodomain inhibitor demonstrating efficacy in vivo and in vitro against multiple myeloma and leukaemia models.Fórmula:C22H18ClN5OCor e Forma:SolidPeso molecular:403.86HDAC3-IN-T247
CAS:HDAC3-IN-T247 (HDAC3 inhibitor T247) is a histone deacetylase 3 (HDAC3) inhibitor with antiviral activity that inhibits the proliferation of cancer cells.Fórmula:C21H19N5OSPureza:98.11% - 98.94%Cor e Forma:SolidPeso molecular:389.47Ref: TM-T24131
1mg92,00€5mg188,00€10mg311,00€25mg643,00€50mg914,00€100mg1.216,00€1mL*10mM (DMSO)215,00€SARS-CoV-2 nsp13-IN-1
CAS:<p>SARS-CoV-2 nsp13-IN-1 (C1) inhibits nsp13 ssDNA+ATPase (IC50: 6 μM), not ssDNA-ATPase; useful for COVID-19 research.</p>Fórmula:C27H20N4O2Pureza:99.44%Cor e Forma:SolidPeso molecular:432.47Tenofovir exalidex
CAS:Tenofovir exalidex (CMX 157) is a lipid-conjugated acyclic nucleotide analog of Tenofovir, demonstrating efficacy against wild-type and antiretroviral-resistantFórmula:C28H52N5O5PPureza:99.83%Cor e Forma:SolidPeso molecular:569.72UC-781
CAS:UC-781, a potent NNRTI, inhibits HIV-1 with a C50 of 5 nM and is stable across pH and temperatures.Fórmula:C17H18ClNO2SPureza:92.17%Cor e Forma:SolidPeso molecular:335.85DDX3-IN-2
CAS:DDX3-IN-2 is a potent DDX3 inhibitor with an IC50 of 0.3 μM and shows broad antiviral effects, including against HIV resistance.Fórmula:C20H23N5OCor e Forma:SolidPeso molecular:349.43EIDD-2749
CAS:EIDD-2749 (4'-Fluorouridine), an oral drug, inhibits RdRp, halts RSV/SARS-CoV-2 replication, and fights HCV/LCMV.Fórmula:C9H11FN2O6Pureza:97.39%Cor e Forma:SolidPeso molecular:262.19Maribavir
CAS:<p>Potent antiviral against HCMV and Epstein-Barr virus (EBV)</p>Fórmula:C15H19Cl2N3O4Pureza:Min. 95%Peso molecular:376.24 g/molDaclatasvir
CAS:<p>Daclatasvir is a direct-acting antiviral agent, which is derived from synthetic chemical sources with a specific mode of action targeting the hepatitis C virus (HCV) replication process. It functions as an inhibitor of the HCV nonstructural protein 5A (NS5A), a vital component necessary for viral RNA replication and virion assembly. By binding to two distinct domains of NS5A, Daclatasvir disrupts its ability to function, thereby effectively halting the replication of the viral genome.</p>Fórmula:C40H50N8O6Pureza:Min. 95%Peso molecular:738.88 g/mol
